Application

PTO- 1478

Approved for use through 07/31/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 07/31/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90807080

Filing Date: 07/01/2021

To the Commissioner for Trademarks:

MARK: SELTOLZA (Standard Characters, see mark)
The literal element of the mark consists of SELTOLZA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Adaptimmune Limited, a limited company (ltd.) legally organized under the laws of United Kingdom, having an address of
      Milton Park
      60 Jubilee Avenue
      Abingdon, Oxford OX144RX
      United Kingdom
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Cell therapy pharmaceutical preparations; immunotherapy preparations; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on United Kingdom application number UK00003662804, filed 06/30/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.


International Class 044:  Cell therapy medical treatment services; immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on United Kingdom application number UK00003662804, filed 06/30/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.




The owner's/holder's proposed attorney information: Christiane Campbell. Other appointed attorneys are Samuel W. Apicelli, Gregory P. Gulia, Nicole K. McLaughlin, Victoria Danta, Lauren Matturri, and Duane Morris LLP. Christiane Campbell of DUANE MORRIS LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      30 South 17th Street
      Philadelphia, Pennsylvania 19103-4196
      United States
      215-979-1817(phone)
      215-689-4910(fax)
      ccampbell@duanemorris.com
The docket/reference number is K0677-00076.
Christiane Campbell submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Christiane Campbell of DUANE MORRIS LLP
      30 South 17th Street
      Philadelphia Pennsylvania 19103-4196
      United States
      215-979-1817(phone)
      215-689-4910(fax)
      ccampbell@duanemorris.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The applicant's current Correspondence Information:

Christiane Campbell

PRIMARY EMAIL FOR CORRESPONDENCE: ccampbell@duanemorris.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): idocketing@duanemorris.com; mlozada@duanemorris.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Christiane Campbell/   Date: 07/01/2021
Signatory's Name: Christiane Campbell
Signatory's Position: Attorney of Record, PA Bar Member
Signatory's Phone Number: 215-979-1817
Signature method: Signed directly within the form
Payment Sale Number: 90807080
Payment Accounting Date: 07/01/2021

Serial Number: 90807080
Internet Transmission Date: Thu Jul 01 17:37:46 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202107011737460
20597-90807080-7805d23ca0de615c4078991e2
c6eb945bd5b4b6ff0c819d5ed1adac1a83c66946
2-DA-37451630-20210701165357412248